MT2A and chronic kidney disease: Enhanced MT1A and MT2A mRNA levels in subjects with chronic kidney disease (p < 0.01, Figure 1A and Figure 2A) compared to NEC rather than EC, and higher metals and metalloid levels (p < 0.05) in EC compared to NEC (Table 2) suggest that elevated plasma burden of metals could be the reason for MT upregulation in an endemic area.